Position in ARDX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$2,915,404
+$1,785,732 QoQ
Shares Held
486,712
+151.2% QoQ
Ownership
0.197%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ARDX Over Time
Shares Held
Position Value (USD)
Derivatives in ARDX
reported options exposure · as of Mar 31, 2026CallValue
$299,500
CallShares
50,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026RAYMOND JAMES FINANCIAL INC holds $1,498,619,160 across 194 Biotechnology names. ARDX ranks #57 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
444,496 | $198,485,243 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
406,956 | $134,649,528 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,542 | $127,904,369 | |
| 4 | INSM |
INSMED Inc
|
775,148 | $126,752,197 | |
| 5 | RPRX |
Royalty Pharma plc
|
1,524,018 | $73,107,140 | |
| 6 | VKTX |
Viking Therapeutics, Inc.
|
2,075,403 | $67,533,612 | |
| 7 | EXEL |
Exelixis, Inc.
|
1,045,595 | $44,845,567 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
156,064 | $40,314,451 |
All Filings in ARDX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,915,404 | 486,712 | Shares | Defined | 2026-05-14 | |
| 2026-03-31 | $299,500 | 50,000 | Call | Defined | 2026-05-14 | |
| 2025-12-31 | $1,129,672 | 193,769 | Shares | Defined | 2026-02-18 | |
| 2025-09-30 | $495,799 | 89,982 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $805,386 | 205,456 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $970,318 | 197,621 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $930,293 | 183,490 | Shares | Defined | 2025-04-23 | |
| No filing history on record for this holder in this stock. | ||||||